The cyclin-dependent kinase inhibitor p21 WAF1/CIP1 (p21) is a cell-cycle checkpoint effector and inducer of senescence, regulated by p53. Yet, evidence suggests that p21 could also be oncogenic, through a mechanism that has so far remained obscure. We report that a subset of atypical cancerous cells strongly expressing p21 showed proliferation features. This occurred predominantly in p53-mutant human cancers, suggesting p53-independent upregulation of p21 selectively in more aggressive tumour cells. Multifaceted phenotypic and genomic analyses of p21-inducible, p53-null, cancerous and near-normal cellular models showed that after an initial senescence-like phase, a subpopulation of p21-expressing proliferating cells emerged, featuring increased genomic instability, aggressiveness and chemoresistance. Mechanistically, sustained p21 accumulation inhibited mainly the CRL4-CDT2 ubiquitin ligase, leading to deregulated origin licensing and replication stress. Collectively, our data reveal the tumour-promoting ability of p21 through deregulation of DNA replication licensing machinery-an unorthodox role to be considered in cancer treatment, since p21 responds to various stimuli including some chemotherapy drugs.
Numerous proteins involved in key cellular processes display bimodality in cancer, acting as either tumour suppressors or oncoproteins (Supplementary Table 1 ). This phenomenon is commonly attributed to 'cellular or environmental context' . Elucidating the mechanism(s) underlying such context-dependent duality is essential for rational design of cancer therapy.
The cyclin-dependent kinase inhibitor (CDKI) p21 (p21) is a pivotal downstream effector of the tumour-suppressor p53, mediating mainly G1-phase arrest and cellular senescence in response to various stimuli 1 . Several studies suggest that p21 can also manifest oncogenic properties (Supplementary Table 1 ). In some studies, the oncogenic function of p21 was credited to unconventional cytoplasmic localization of p21 that inactivates pro-apoptotic proteins 2, 3 . Still, in most cases the underlying mechanism remains obscure. Notably, while p53 is frequently mutated in cancer 4 , p21 is rarely affected genetically 1, 5 . The latter would be logical if p21 operated exclusively within the p53 pathway. However, p21 is activated also by diverse p53-independent signals 1 .
Replication licensing ensures that genome replication takes place once per cell cycle 6, 7 , due to the periodic expression of the replication licensing factors (RLFs) ORC, CDT1 and CDC6 that increase in late M to G1 phases and decrease in S/G2 phases 8 . Deregulation of the replication licensing process promotes genomic instability and tumorigenicity, mainly via unscheduled DNA re-replication [9] [10] [11] [12] . Aberrant expression of RLFs occurs in diverse malignancies 13, 14 .
Here we present a pathophysiological mechanism demonstrating that protracted p21 expression, in a p53 loss-of-function environment, causes deregulation of the replication licensing machinery, replication stress and genomic instability.
RESULTS

A subset of atypical p21-expressing cells in advanced-stage tumours and preneoplastic lesions show signs of proliferation
In an array of human tumours we observed an intriguing relationship between p21 and the proliferation marker Ki67. While the anticipated mutually exclusive expression pattern of p21 and Ki67 was prevalent, consistent with the growth-inhibitory properties of p21, there were a number of atypical cancer cells co-expressing p21 and Ki67 (Fig. 1a-c) . Atypical cancer cells commonly point to adverse prognosis 15 . Most of the carcinomas examined displayed p53 alterations 13, 14, 16 . In preneoplastic lesions with p53 aberrations we noticed a similar phenomenon (Fig. 1d ) 17 . The unexpected co-expression of p21 with Ki67 suggests either tolerance to high p21 levels, or selection under chronic p21 expression allowing for emergence of a subpopulation of p21-positive cells that regained proliferative capacity and possibly acquired enhanced aggressiveness.
p53-independent expression of p21 upregulates RLFs
To address the impact of constitutive p21 expression in a p53-deficient context we employed two doxycycline-inducible (Tet-ON) p21-expressing cellular systems: one recapitulating the cancerous stage, based on Saos2, a p53-null human osteosarcoma cell line (Saos2 p21 Tet-ON), and the other reflecting the precancerous stage by expressing the inducible module in the Li-Fraumeni-derived fibroblasts (MDAH041-Li-Fraumeni p21 Tet-ON) (Fig. 1e) . The MDAH041 fibroblasts are p53-null human cells, considered 'near'-normal, as they are reminiscent of normal diploid cells when p53 is restored, suggesting that their downstream functions are largely intact 18 . To avoid heterogeneity of p21 expression in bulk cell cultures, we isolated p21-inducible clones that expressed p21 levels comparable to those observed in vivo and in cells exposed to genotoxic agents or p53-independent p21-inducing stimuli (such as TGF-β) 1 (Fig. 1e) . Apart from monitoring cell proliferation, transcriptome and proteome landscapes were examined at distinct time points (Fig. 1e ) after p21 induction to identify candidate pathways/networks that could over time exercise an 'oncogenic' effect (Supplementary  Tables 2-9 ). Representative high-throughput results were confirmed independently by quantitative real-time PCR and immunoblotting ( Fig. 2a and Supplementary Fig. 1ai -ii). As expected 19 , the p21-expressing clones reduced their growth rate and progressively acquired a senescent phenotype that peaked around day 10 ( Supplementary Fig. 1b and Supplementary Videos 1-3). Consistent with such phenotypical changes, Gene Ontology biological process enrichment analyses revealed suppression of key 'mitosis' factors (Supplementary Fig. 1a and Supplementary Tables 2-9 ). Unexpectedly and counter-intuitively, the proteome analysis revealed prominent upregulation of the RLFs: CDT1, CDC6 and ORC (P = 1.5 × 10 −6 ); with CDT1 protein increase being the earliest biochemical alteration among all measured parameters (Supplementary Tables 2-9 ). The increase of the RLFs was not accompanied by elevated messenger RNA, implying post-transcriptional regulation (Fig. 2a) . Similar results were observed in the Li-Fraumeni p21-inducible cells (Fig. 2b) . Notably, p21, CDT1 and CDC6 share the same E3-ubiquitin ligase, CRL4-CDT2 (refs 8,20) . Continuous p21 expression might saturate its enzymatic activity leading to CDT1 and CDC6 accumulation (Fig. 2c) . Consistently, SET8 methyltransferase, a known target of CRL4-CDT2 (ref. 21) , was upregulated after p21 induction (Fig. 2c) . Shutting-off p21, after a period of induction, led to a ubiquitylationdependent decrease of CDT1 (Fig. 2d) . Furthermore, transiently expressed mutant p21 (mut)PCNA , which avoids p21 degradation by CRL4-CDT2, did not augment CDT1 and CDC6 abundance (Fig. 2e ) 20 . Also, induction of wild-type p21, but not the p21
(mut)PCNA mutant, resulted in CDT1 and CDC6 accumulation (Fig. 2f ). Given that p21 has the strongest affinity amongst all PCNA-interacting proteins (K d ∼ 2.5 nM) (ref. 22) these results strongly support a mechanism whereby excessive p21 saturates its own ubiquitin ligases allowing accumulation of other targets such as CDT1 and CDC6. The increase of G1-phase cells caused by p21 induction possibly also contributed to the observed reduced RLF protein turnover, as RLFs are normally protected from degradation in G1 (Fig. 2g) . Moreover, CDC6 accumulation under conditions of blocked protein synthesis was not further enhanced on proteasome inhibition, suggesting reduced protein turnover of CDC6 (Fig. 2h ), possibly also due to reduced activity of APC Cdh1 , another E3 ligase that targets CDC6 for degradation 23 . Indeed, abundance of FZR1 (also known as CDH1), the substrate recognition and activating component of the APC was decreased (Fig. 2i) . Downregulation of FZR1 contributes to high E2F1 levels ( Fig. 2c and Supplementary Fig. 1ci -ii) 24, 25 , thereby further boosting CDT1 expression 13 . Enhanced CDC6 stability was associated with Cdk2-mediated phosphorylation at Ser54 (CDC6-pS54) that protects CDC6 from degradation ( Fig. 2h ) 23 . Despite p21-mediated Cdk2 activity decrease ( Supplementary Fig. 1ciii ), reduction of FZR1 appears to tilt the balance in favour of CDC6 accumulation (total and CDC6-pS54) (Fig. 2h) . Notably, protein synthesis and proteasome inhibition did not restore FZR1 protein levels, implying regulation at the transcriptional level, a notion confirmed experimentally (Fig. 2i) .
Given that most clinical specimens with p21/Ki67 double-positive cells were p53-deficient, we examined whether p53 impacts the ability of p21 to regulate the CDT1 and CDC6 levels, as previously suggested 26 . Indeed, p21 expression in p53-defective and p53 wildtype (WT p53) cell types resulted in increased (Figs 2c and 3a,d), and suppressed (Fig. 3b ,c,e) RLF abundance, respectively. It was suggested that p53 shields the organism from cells undergoing rereplication by triggering apoptosis 26 . Consistently, after p21 induction WT p53 HT1080 p21-IPTG-ON cells experienced massive apoptosis, accompanied by a dramatic decrease of CDT1 and CDC6 (Fig. 3e) . Conversely, silencing of p53 suppressed apoptosis and allowed upregulation of CDT1 and CDC6 (Fig. 3e) . Similar results were obtained on p53 restoration in the Saos2 cellular system (Fig. 3c ) 27 . Fraumeni p21 Tet-ON and Saos2 p21 Tet-ON cells, showing time points where main biochemical and phenotypical events occur. IHC and IF: black and white thin arrows denote p21 and Ki67 co-expressing cells, respectively; IF: white and yellow thick arrows depict cells with mutually exclusive p21 and Ki67 expression, respectively. Scale bars in IHC panels, 50 µm; IF panels, 50 µm. Unprocessed original scans of blots are shown in Supplementary Fig. 9 .
Last, exposure to p53-independent p21-inducing stimuli such as TGF-β led to upregulation of both RLFs (Fig. 3d) .
Expression of p21 in p53-null cells triggers replication stress in a CDT1/CDC6-dependent manner Re-replication is a form of replication stress driven mainly by inappropriate expression of RLFs 6, 8, 9 , leading to DNA damage and DNA damage response (DDR) activation 6, 9 . Following p21 induction in both, Saos2 and Li-Fraumeni p21 Tet-ON cellular systems, chromatin loading of the MCM2-7 helicase complex increased robustly, indicating that CDT1 and CDC6 upregulation is functional ( Supplementary Fig. 1d ). Flow cytometry analysis of cells doublestained for DNA content and DNA synthesis revealed a cell subpopulation with DNA content greater than 4n, indicative of rereplication ( Fig. 3f-h and Supplementary Video 4). Subsequently, DNA damage, assessed by the alkaline comet assay (total number of DNA lesions) and pulsed-field gel electrophoresis (PFGE) was evident and accompanied by DDR, documented by H2AX phosphorylation (γH2AX) and increased 53BP1 foci formation (Fig. 4a-e and Supplementary Fig. 1ei-iv) . Strikingly, re-replication, DNA damage and DDR activation were CDC6-and CDT1-dependent, further suggesting that deregulated p21 causes replication stress associated (c) CDT1 stabilization possibly via suppression of the CRL4-CDT2 ubiquitin ligase complex due to overabundance of p21. (d) Ubiquitylation-dependent decrease of CDT1 levels following p21 switch-off. Doxycycline-induced Saos2 p21 Tet-ON cells were subsequently shut off for the indicated time points and treated also with 30 µM MG132 ( * P < 0.0001, ANOVA, error bars indicate mean ± s.d., n = 3 blots). IB, immunoblot. (e) Saos2 cells were transfected with wild-type p21 and a specific p21 mutant (p21 (mut)PCNA : harbouring Gln144, Met147, Phe150 substitutions to alanine in its PCNA-interactingprotein (PIP) degron motif-see panel below) abrogating its interaction with PCNA. (Empty vector: pMSCV, p21: pMSCV-p21, p21
(mut)PCNA : pMSCVp21 (mut)PCNA .) (f) Induction of p21 (mut)PCNA abrogated upregulation of CDT1 and CDC6 in Li-Fraumeni cells. The panel below e and f presents p21 protein structure and domains. Location of mutations in the PIP motif of p21 (mut)PCNA is also depicted. (g) CDT1 and CDC6 reduced turnover due to the cell-cycle profile imposed by constitutive p21 expression. (h) Stabilization of CDC6 by p21 overexpression. (i) Real-time RT-PCR assessment of FZR1 in induced and non-induced Saos2 and Li-Fraumeni p21 Tet-ON cells ( * P = 0.02108 (Saos2), * P = 0.00479 (Li-Fraumeni), t-test, error bars indicate mean ± s.d., n = 3 experiments). Actin and vinculin serve as loading controls; GAPDH serves as a normalizing housekeeping gene; h, hours; MG132, proteasome inhibitor; CHX, cycloheximide. Unprocessed original scans of blots are shown in Supplementary Fig. 9 . Source data are available in Supplementary  Table 25 . induction that is CDT1-and CDC6-dependent ( * P < 0.0001, ANOVA, error bars indicate mean ± s.d., n = 5 experiments). Similar analysis using the p21 (mut)PCNA mutant (h; see also the panel under Fig. 2e ,f) abrogated rereplication (P = not significant, t-test, error bars indicate mean ± s.d., n = 5 experiments). Actin serves as a loading control. Ctl, control shorthairpin RNA; d, days; h, hours. Unprocessed original scans of blots are shown in Supplementary Fig. 9 . Source data are available in Supplementary  Table 25 .
with re-replication ( Fig. 4b-e) . Likewise, silencing of p21 alleviated DNA damage and DDR (Supplementary Figs 1eiii,iv and 2ai-iii). DNA damage reduction was negligible on deoxynucleoside 5 -triphosphate supplementation, in contrast to the impact of CDT1 and CDC6 silencing (Fig. 4d) 
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. Finally, re-replication and DNA damage were significantly reduced when the p21 (mut)PCNA mutant was employed, and replication fork asymmetry on sustained p21 expression ( * P < 0.001, P < 0.002, t-test, ± indicate s.d., n values represent the number of forks analysed across two experiments). Saos2 p21 Tet-ON non-induced versus induced cells (96 h) after 20 min consecutive labelling pulses of CIdU (red) and IdU (green) were subjected to DNA fibre analysis. (h,i) Protracted p21 expression inflicts DNA damage in S phase in Saos2 p21 Tet-ON (h) and Li-Fraumeni p21 Tet-ON cells (i). FACS of p21-induced cells for 96 h and co-stained for γH2AX/propidium iodide (PI), with or without anti-CDC6/CDT1 siRNA targeting, and p21-induced cells for the indicated time points and co-stained for EdU/γH2AX. Histograms for γH2AX/PI depict counts in rectangular areas (both dashed and not) ( * P < 0.0001, ANOVA and t-test respectively, error bars; mean ± s.d., n = 5 experiments). Actin, H2AX and vinculin serve as loading controls; Ctl, control siRNA; d, days; h, hours. Unprocessed original scans of blots are shown in Supplementary Fig. 9 . Scale bars, 7.5 µm (c,e) and 50 µm (b,d,f). Source data are available in Supplementary Table 25 . consistent with our model that excess p21 acts by suppressing PCNAdependent ubiquitylation of CDT1 and CDC6 (Figs 2f, 3h and 4f and Supplementary Fig. 1ei ,ii) 8 . It seems paradoxical that p21 could trigger replication stress, given its role as a potent cell-cycle inhibitor. Nevertheless, DNA combing showed that replication fork progression did not cease, but its speed was reduced (Fig. 4g ). In addition, replication fork asymmetry was observed, possibly related to the presence of DNA lesions impeding bi-directional fork movement (Fig. 4g) . Consistently, multi-parameter flow cytometry analysis of γH2AX, DNA content and DNA synthesis showed that, following p21 induction, DNA damage accumulated mainly in cells incorporating EdU, whereas depletion of CDC6 and CDT1 profoundly suppressed the accumulation of DNA damage in S phase (Fig. 4h,i) . Markedly, the cells expressing p21 demonstrated a focal PCNA pattern typical for early S phase ( Supplementary Fig. 2b ) 29 , suggesting that DNA damage occurs at a sensitive period when particularly active genes and early-replication fragile sites are replicated 30 .
p21-induced replication intermediates are processed by MUS81-EME1 and repaired by a Rad52-dependent mechanism
To further characterize p21-induced replication stress, we examined single-stranded DNA (ssDNA) formation, a common intermediate at replication-associated lesions. To this end, p21-expressing cells were incubated with BrdU under non-denaturating conditions, allowing anti-BrdU staining to selectively visualize ssDNA regions 31 . In situ analysis showed a strong correlation between the native BrdU staining and p21 expression (Fig. 5a,b ) that was also associated with an increased number of foci formed by the ssDNA-binding protein RPA (Fig. 5c) . The ssDNA could occur on either the template or the newly synthesized (nascent) strand [32] [33] [34] . BrdU staining was absent on short BrdU pulses, suggesting that the source of ssDNA is the template strand ( Supplementary Fig. 2c ).
Next, we inspected replication intermediates in vivo by an established electron microscopy method 35 . Compared with the WT p53 U2OS cell line 36 , in unperturbed Saos2 cells we found pronounced accumulation of the so-called reversed forks (Fig. 5di) , four-way DNA junctions that have been proposed to limit the amount of exposed ssDNA and thereby possibly mitigate the detrimental impact of gross replication stress 36, 37 . Expression of p21 in the Saos2 cell model led to a marked accumulation of small replication bubbles (Fig. 5dii) , decreased fork reversal and enhanced accumulation of ssDNA stretches at replication forks, with most small bubbles showing one side entirely single-stranded (hemireplicated) (Fig. 5di,iii) . Overall, these data are consistent with the notion that p21 expression in p53-defective cancer cells deregulates origin firing, leading to accumulation of ssDNA and increased replication stress.
Replication intermediates need to be resolved for replication to restart. After long periods of replication inhibition, doublestrand breaks generated by the structure-specific resolvase complex of MUS81-EME1 are required for replication restart 32, 38 . We hypothesized that sustained p21 expression may phenocopy this state. Indeed, MUS81-EME1 depletion caused a significant DNA damage decrease, inflicted by p21 expression, as well as reduction of EdU-positive cells harbouring signs of DNA damage (Fig. 5e-g and Supplementary Fig. 2di ,ii). MUS81-EME1 is considered a central player in oncogene-induced DNA damage response 39, 40 , promoting homologous recombination-mediated repair of inactivated (collapsed) forks 32 . Surprisingly, we noticed that silencing of the homologous recombination recombinase Rad51 resulted in decreased γH2AX levels (Fig. 5h) . This finding implies a negative control over an alternative, Rad51-independent, repair process. Rad51 seems to exert such an effect preventing Rad52-dependent DNA repair 41 . Indeed, suppression of Rad52 was followed by increased γH2AX and cell death in both p21-induced models ( Fig. 5i-k) , suggesting that Rad52 guided the repair process. Rad52 is possibly involved in error-prone microhomology-mediated repair pathways challenging genomic stability 42, 43 . Interestingly, Rad51 levels were reduced on p21 induction ( Fig. 5h and Supplementary Fig. 2diii ). Rad51 is in short supply and under stressful conditions, such as hypoxia, Rad51 is repressed by E2F4/p130 complexes. Such complexes are recruited by p21 to mediate gene repression 44 . In accordance, the promoter of Rad51 was occupied by E2F4 ( Fig. 5l) , providing an explanation of why Rad52 is chosen for repair in this setting.
Deregulated CDT1 and CDC6 link p53-independent p21 induction with senescence Sustained p53-independent p21 expression triggered senescence, a well-established antitumour barrier, in a CDT1-and CDC6-dependent manner (Fig. 6a,b) 14,45 . Consistently, no signs of senescence were observed when the p21 (mut)PCNA -inducible mutant was employed or p21 was silenced ( Fig. 6c and Supplementary Fig. 2ai -iii). As p73, the p53 homologue, responds to DDR signalling 46 , we asked whether p73 could operate downstream in the emerging p21-RLFs-DDR-signalling route. Indeed, p73 proved to be required for the p21-CDT1/CDC6-induced senescence (Fig. 6d,e) .
According to the oncogene-induced DNA damage concept for cancer development, the DDR-mediated anti-tumour barriers are breached at some point in tumours that progress, accompanied by genomic instability 12 . If this concept is applicable for chronic p53-independent p21 induction, then in due time the p21-expressing cells could bypass the senescence barrier generating more aggressive outgrowing clones. CDC6 overexpression per se could contribute to senescence bypass by repressing the INK4/ARF locus 47 , encoding p16
INK4A , an indispensable factor of irreversible senescence 48 . Indeed, p21 activation led to downregulation of both INK4/ARF products, p16 INK4A and p14 ARF , undermining the durability of p21-mediated senescence (Fig. 6f,g ).
Senescence bypass, genomic instability and enhanced aggressiveness under protracted p21 expression After 10 days of p21 induction in p53-deficient models the senescent phenotype gradually declined and a subpopulation of proliferating p21-positive cells emerged ( Fig. 7a -e and Supplementary Video 5). Likewise the mutually exclusive expression pattern of cyclin A-an established late S/G2 marker 49, 50 -and p21 was reduced and replaced by a p21/cyclin A double-positive cell subpopulation (Fig. 7f ). It appears that a fraction of p21-expressing cells evaded arrest/senescence, re-entering the cell cycle ('escaped cells'). Cdk2 activity and its stimulatory phosphorylation (pT160) were concomitantly restored ( Fig. 7g and Supplementary Fig. 2ei ). Notably, p21 set of analysed molecules ( * P ≤ 0.001; Mann-Whitney test) (the numbers in brackets denote the total number of analysed molecules) (P, parental duplex; D, daughter duplexes; R, regressed arm). (e-g) p21-mediated DNA damage is processed by MUS81 resolvase ( * P < 0.0001, ANOVA). Red lines in insets, comet (moment) tails; scale bars, 50 µm (e,g). FACS of Saos2 p21 Tet-ON induced cells for 96 h and co-stained for EdU/γH2AX, with or without anti-MUS81 silencing (f). (h) Silencing of Rad51 resulted in decreased γH2AX levels ( * P < 0.01, t-test). (i-k) Suppression of Rad52 was followed by increased γH2AX expression and cell death ( * P < 0.0001, ANOVA), as shown by immunoblots (i,k) and FACS analysis (j). (l) The Rad51 promoter is occupied by E2F4 on p21 induction as assessed by chromatin immunoprecipitation (ChIP) ( * P < 0.000913, t-test). Actin and H2AX, loading controls; Ctl, control siRNA; h, hours. Unprocessed original scans of blots are shown in Supplementary Fig. 9 . Error bars indicate mean ± s.d., n = 3 experiments in comet assays (e,g), blots (h,i,k) and ChIP (l); n = 5 experiments for FACS analyses (f,j). Source data are available in Supplementary Table 25 .
expression in the 'escaped' cells was similar to, or even higher than, that observed in the initial phase of p21 induction, excluding the possibility that low p21 stoichiometric concentrations drive proliferation ( Fig. 7g and Supplementary Fig. 2eii ,iii) 1 . The 'escaped' cells showed a dramatic reduction of p73 expression (Fig. 7g,h ). There was no evidence of genetic or epigenetic inactivation of the p73 locus but instead downregulation of EGR1, the main transcriptional activator of TP73 (Supplementary Figs 2f and 3-5 ) 51 . The nuclei in most 'escaped' cells were larger than those in the cycling control cells (Fig. 7i and Supplementary Video 5) , a feature noticed also in vivo (Figs 1 and 7j and Supplementary Fig. 2g ). Noticeably, in vivo, the cells displaying Ki67/p21 co-expression were also CDC6 and/or CDT1 positive ( Fig. 7j and Supplementary Fig. 2g ). DNA damage was also reduced in the 'escaped' cells, implying that a repair process took place (Fig. 7k) . The involvement of the MUS81-EME1-Rad52 repair route (Fig. 5e-k) and the increased presence of micronuclei (Fig. 8a ) that are considered surrogate markers of chromosomal instability, defective DDR and repair 52 indicated that such repair was error-prone. To gain a genome-wide view of this emerging scenario we performed array comparative genomic hybridization (aCGH), deep sequencing and multicolour fluorescence in situ hybridization/spectral karyotyping (M-FISH/SKY) comparing the 'escaped' and the non-induced cells ( Tables 13-15) . Notably, a high frequency of microhomologies (≥2 nucleotides) 42 was identified adjacent to the novel breakpoints in both systems, favouring a role of microhomology-mediated repair in p21-driven genomic instability (Fig. 8d,e and Supplementary Fig. 7 and Supplementary  Table 16 ). Interestingly, among the genetic lesions found were alterations reminiscent of chromoanasynthesis or chromothripsis (Fig. 8b,c and Supplementary Tables 10 and 11) 53 . Given that the multifaceted chromosomal assessment showed concordant results ( Fig. 8d-g and Supplementary Figs 4-6) and each experimental procedure took place at different time periods, we propose that p21 may steer a 'deterministic' set of genetic events that may play a role in the behaviour of the 'escaped' cells. In line with this notion the transcriptome of the 'escaped' cells ( Supplementary Figs 3 and 8 ) demonstrated a specific nonrandom correlation with the genomic alterations found in these cells (P < 2.2 × 10 −16 for the Saos2 and P = 0.0013 for the Li-Fraumeni cells). Deregulation of the replication licensing machinery was the earliest biochemical event observed on p21 induction, further suggesting that genomic instability 'drove' the alterations in transcriptome landscapes of the 'escaped' cells. While p21 is not a transcription factor it can modulate transcription in certain cases 54 . However, the fact that only 42 (7.6%) of the 553 genes and 538 (15%) of the 3,507 genes found differentially expressed in the 'escaped' Saos2 and Li-Fraumeni p21 Tet-ON cells, respectively, were detected in earlier time points makes the scenario of more 'direct' transcriptional effects of p21 most unlikely ( Supplementary Fig. 8 ).
Importantly the 'escaped' clones demonstrated enhanced anchorage-independent growth and were more invasive (Fig. 8h,i,l) . Furthermore, they tolerated treatment with the genotoxic drugs doxorubicin and cisplatin much more efficiently, yet showed no significant difference in the response to taxol, a microtubule polymer stabilizer. The enhanced resistance to doxorubicin and cisplatin persisted even when p21 was switched off in the 'escaped' cells for 10 days, documenting that this feature was a durable consequence, independent of any potential p21-mediated transient Supplementary Fig. 9 . Source data are available in Supplementary  Table 25 . Table 25 .
transcriptional effect (Fig. 8j,m) . This chemoresistance effect was absent when p21 was silenced very early after p21 induction ( Supplementary Fig. 2ai-iii) . A number of the transcriptionally altered genes connected with aggressive behaviour could help interpret the acquired aggressive phenotypic features ( Supplementary  Fig. 3d ,e and Supplementary Tables 17-22 ). Furthermore, assessments of tumour sphere formation and anchorage-independent growth indicated that the 'escaped' populations are enriched in cells with 'stemness'-like features ( Fig. 8k and Supplementary Fig. 3d ).
DISCUSSION
The present data set demonstrates an unexpected p21-mediated oncogenic mechanism that is distinct from that reported for leukaemia stem cells 55 . It also explains why p21 is only transiently expressed during induction of senescence 48, 56 and how p53 inactivation can tip the balance towards the oncogenic function of p21.
When free from the influence of WT p53, p21 induced by p53-independent signals causes deregulation of the replication licensing machinery triggering replication stress. We provide evidence that continuous production of p21 suppresses its degradation module, CRL4-CDT2, possibly by oversaturating it as p21 has the strongest PCNA-binding affinity ( Supplementary Fig. 8c ) 22 , thereby leaving their other targets, including CDT1, CDC6 and E2F1, unabated to perform their functions (Supplementary Fig. 8c ). Since CDT1 expression is positively regulated by E2F1 (ref. 13) , such a feed-forward mechanism could further boost CDT1 expression (Supplementary Fig. 8c ). Although CRL4-CDT2 seems to be the key player in this process, SCF Skp2 , which also targets p21 and CDT1, may also contribute 1, 22, 57 . By upregulating the pivotal replication licensing factors CDT1 and CDC6, the cells expressing p21 acquire the capacity to re-replicate (or 'endo-reduplicate'), a phenomenon that we now explain mechanistically 58 . We show that p21-mediated genome re-replication eventually drives a chromosome-destabilizing process giving rise to descendant cells with more aggressive cancerous features (Supplementary Fig. 8c ). Re-replication is a form of replication stress that leads to replication fork stalling, collapse, DNA damage and eventually genomic instability 8, 9, 59 . Within this context, the p53 checkpoint was shown to limit re-replication, via eliminating re-replicating cells by apoptosis (Fig. 3b ) 26 . The fact that the turnover of p21, CDT1 and CDC6 is controlled by the same E3-ubiquitin ligase, CRL4-CDT2, underscores the significance of p53 whose inactivation abolishes a cell-protective mechanism. Given that p21 mutations are extremely rare events in cancer 1, 5 , it is apparent that human cancers with mutant p53 are at risk of suffering additional deleterious, tumour heterogeneity-promoting genetic alterations by protracted operation of p21, induced through p53-independent signals ( Supplementary Fig. 1eiii,iv) 1 . The ensuing involvement of MUS81-EME1 and the recombinase Rad52 point towards a replication-based error-prone DNA repair process 39, 40 . Reduction of Rad51 elicits a switch from high-fidelity homologous recombination to a lower-fidelity repair process mediated by Rad52 that requires much less homology (microhomology) (Supplementary Fig. 8c ) 41, 42, 60 . The altered genomic landscape and the high frequency of microhomologies found within and adjacent to the mapped breakpoints supports this scenario (Supplementary Figs 4-7) . Among the chromosomal aberrations observed, chromoanasynthesis results from replicative template-switching events (Fig. 8b,c) 
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. However, chromothripsis, another complex chromosomal rearrangement pattern noticed here (Fig. 8b,c) , is considered to be the outcome of non-homologous end joining 62 , implying that other repair pathways, possibly non-replicative ones, may also contribute to the p21-driven genomic instability.
A question that always emerges is whether genomic alterations represent a passenger or a driver event. The strong correlation between the transcriptome and genome changes supports the latter possibility. Among the transcripts found deranged were growth factors and metalloproteinases that could account for the aggressive behaviour of the 'escaped' cells ( Supplementary Fig. 3 and Supplementary  Tables 17-22) . Notably, ID1, shown to antagonize the suppressive effects of p16 INK4A and p21 (ref. 63) , was upregulated in the 'escaped' cells ( Supplementary Fig. 3) .
Collectively, p21-driven genomic instability constitutes part of a selection trajectory to promote survival and long-term cancer evolution 64 , as illustrated mainly by the increased aggressiveness and resistance of the 'escaped' cells to genotoxic agents. This tumour evolutionary scenario involves a combination of p53 defects permissible for passage through a reversible senescence phase (Fig. 6f,g ) 48, 57 that 'conceals' an underlying replication stress-based/error-prone repair route that over time ensures that the 'fittest and more adapted cancer cells' emerge 10 . Our results highlight the 'dark side' of p21 that should be taken into consideration when designing therapeutic strategies, particularly for p53-deficient tumours, as agents used in clinical oncology, such as dexamethasone, can induce p21 in a p53-independent manner with potential detrimental effects to patients 65 .
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. 
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METHODS
Tumour specimens. Formalin-fixed, paraffin-embedded sections from 20 headneck carcinomas, 30 urothelial bladder carcinomas, 30 lung carcinomas and 5 dysplasia-associated lesions or masses from patients with ulcerative colitis, which exhibit early p53 aberrations 17 , were analysed and have been previously described 14, 67 . Patients had not undergone any chemo-, immune-or radiotherapy. Protocols for clinical sample collection and their experimental use were approved by the BioEthics Committee of Medical School of Athens, in accordance with the Declaration of Helsinki and local laws and regulations, following also written consent from the patients.
Cell lines and culture treatments. Cell lines were maintained in DMEM (Invitrogen) with 10% FCS (Invitrogen), 2 mM L-glutamine (Invitrogen), and 100 µg ml −1 penicillin and streptomycin (Invitrogen) at 37 • C and 5% CO 2 .
p21 and p21 (mut)PCNA were subcloned from pRc-CMV vectors into pLVXTRE3G, correspondingly. Inducible Li-Fraumeni p21 Tet-ON, Li-Fraumeni and Saos2 p21
(mut)PCNA Tet-ON cells were generated by introducing the p21-and the p21 (mut)PCNA -carrying pLVXTRE3G vectors in MDAH041 (Li-Fraumeni) fibroblasts and Saos2, respectively 18 . Clones with clear p21 and p21 (mut)PCNA expression were selected.
Tet-ON inducible cell lines were treated with 1 µg ml −1 doxycycline (Applichem) and HT1080 p21-9 cells with 100 µM IPTG (Ambion). Saos2 and MDA-MD-234 were treated with 5 ng ml −1 TGF-β, while MCF cells with 2 µM doxorubicin (Sigma).
Microphotographs were obtained with an inverted microscope (Axiovert S100; Carl Zeiss) equipped with CP-Achromat objectives and a CCD (charge-coupled device) IRIS colour video camera (SSC-C370P; Sony), using Image Pro Plus v3.0 (Media Cybernetics) software.
No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. All cell lines have been authenticated by STR profiling and are regularly tested to exclude mycoplasma contamination. siRNA transfections and retrovirus infections. CDC6, CDT1, Rad52, Rad51, p21, FZR1 (Thermo Scientific) and Mus81, p73 (Santa Cruz) siRNA gene silencing was performed as described, following the manufacturer's instructions 46 . Saos2 cells were transiently infected with pMSCV, pMSCV-p21 or pMSCVp21 (mut)PCNA (a mutant p21 harbouring Gln144, Met147 and Phe150 substitutions to alanine in its PIP degron motif) vectors using the Phoenix helper-free retrovirus producer cell line as previously described 49 .
Immunohistochemistry. Immunohistochemistry was performed as previously published using the UltraVision LP Detection System (no. TL-060-HD, Thermo Scientific) according to the manufacturer's instructions 67 . Primary antibodies are described in Supplementary Table 23 . Evaluation and controls for Ki67 and p21 have been previously described 67 .
Indirect immunofluorescence. Indirect immunofluorescence analysis was performed as previously published 14 . Primary antibodies are described in Supplementary Table 23 . Secondary antibodies were Alexa Fluor 488 goat anti-rabbit (Invitrogen, no. A11034, 1:500) and Alexa Fluor 568 goat anti-mouse (Invitrogen, no. A110-31, 1:500). Image acquisition of multiple random fields was automated on a ScanR screening station (Olympus) and analysed with ScanR (Olympus) software, or a Zeiss Axiolab fluorescence microscope equipped with a Zeiss Axiocam MRm camera and Achroplan objectives, while image acquisition was performed with AxioVision software 4.7.1.
Electron microscopy analysis of DNA RIs in human cells. The procedure was performed as previously described 35 . Images were obtained with a transmission electron microscope (Tecnai G2 Spirit; FEI; LaB6 filament; high tension ≤120 kV) equipped with a side-mount CCD camera (2,600 × 4,000 pixels; Orius 1000; Gatan), processed with DigitalMicrograph Version 1.83.842 (Gatan) and analysed with ImageJ (National Institutes of Health). Fig. 1di ) was performed as described before 12, 14 . Primary antibodies are described in Supplementary Table 23 . Thirty micrograms of protein from total extracts or 1 µg of histones per sample was adjusted with Laemmli buffer (Sigma) and loaded on acrylamide/bis-acrylamide gels. Gel electrophoresis, transfer to PVDF membrane (Millipore) and signal development with nitro blue tetrazolium/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP) solution (Molecular Probes) or chemiluminescence were performed as previously described 12 . Alkaline phosphatase-conjugated anti-mouse or anti-rabbit secondary antibody (1:5,000 dilution) (Promega) was used.
Protein extraction, cell fractionation and immunoblotting. Protein extraction and cell fractionation (Supplementary
In vivo ubiquitin assay. Saos2 p21 cells were treated with MG-132 proteasome inhibitor (MERCK) for 3 h at 30 µM at the time points indicated (Fig. 2d) . Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 1% sodium deoxycholate, 1% Triton X-100, protease inhibitor cocktail (Thermo Scientific), phosphatase inhibitor cocktail (Thermo Scientific), N -ethylameleimide deubiquitylase inhibitor (Applichem)). Protein lysates were precleared with protein G agarose beads (Millipore) for 1 h and then incubated with G-protein beads bound to CDT1 antibody (Supplementary Table 23 ) for 2 h at 4 • C. Beads were washed three times in RIPA buffer containing protease, phosphatase and deubiquitylase inhibitors, as above. Protein was eluted from beads with 2× SDS-β-mercaptoethanol sample buffer, boiled for 8 min and loaded on polyacrylamide gels for SDS-PAGE as described above. Blots were blocked for 1 h in 5% BSA in TBS-0.1% (v/v) Tween-20 solution at room temperature. Membranes were incubated overnight with CDT1 antibody (Supplementary Table 23 Chromatin immunoprecipitation (ChIP) assay. ChIP assay was performed as previously described 12 . A 100 bp fragment in the Rad51 promoter and a 110 bp amplicon, located approximately 1,000 bp from the transcription start site (Fig. 5l) , were amplified. Primers and annealing temperatures are provided in Supplementary  Table 24 . PCR reactions containing 1% of the total chromatin extract used in the immunoprecipitation reactions were used as inputs.
Comet assay. The comet assay was performed as previously described 12 . Cells were observed under a Zeiss Axiolab fluorescence microscope equipped with a monochrome CCD camera. Analysis was conducted with Cometscore software (Tritek). All experiments were performed in triplicates.
Pulsed-field gel electrophoresis.
This technique has been previously described 31 .
DNA fibre spreadings. This technique was conducted as previously described with slight modifications 45 . Briefly, Saos2 p21 cells were grown in the presence or absence of doxycycline for 4 days and then pulsed-labelled with 25 µM CldU for 20 min, and then labelled with 250 µM IdU for 20 min. Cells were then harvested and lysed on glass slides in spreading buffer. The DNA was denatured and stained with rat anti-BrdU/CldU (1:1,000, OBT0030F, Immunologicals Direct) and mouse anti-IdU/BrdU (1:500, clone B44, Becton Dickinson) primary antibodies.
Isolation of nucleic acids and bisulfate treatment. DNA extraction was performed as previously described 14 . RNA was extracted with the RNeasy Mini Kit (no. 74104, Qiagen). For assessing DNA methylation levels of p73 promoter, 1 µg DNA was bisulfite-converted using the EZ-DNA Methylation Gold kit (ZymoResearch) as per the supplier's guidelines and eluted in 30 µl of elution buffer.
cDNA preparation and real-time quantitative PCR with reverse transcription (RT-rt-qPCR). cDNA generation and RT-rt-qPCR analysis was run as described before 67 . DNA methylation levels for p73 promoter were assessed by high-resolutionmelting (HRM) analysis. The reaction was performed in a StepOne Real time machine (Life Technologies) using Universal Master Mix II without UNG containing SYBR (Life Technologies) and 200 nM primers. A dissociation (melt) curve programme followed at the end of 40 cycles. Signal analysis was carried out using the StepOne v2.3 software. SssI-methylated and -unmethylated DNA was run in parallel as positive and negative controls, respectively. Primer sequences and annealing temperatures are provided in Supplementary Table 24 . Results are presented as n-fold changes for the various time points after p21 induction versus the values of the non-induced sample. Mean value was calculated from three independent measurements.
Flow cytometric analysis (FACS).
Cell-cycle analysis was assessed on a FACS Calibur (Becton Dickinson) as described before 14 . For BrdU pulse-chase proliferation assays, cells were pulse-labelled with 10 µM BrdU (Roche) for 1 h, fixed in 70% ethanol, and incubated in 2 M HCl for 30 min. Cells were incubated with mouse antibody against BrdU (1:100) for 1 h. For EdU analysis, cells were either pulsed for 10 min or 24 h with 10 µM EdU. Cells were fixed in 70% ethanol and incubated with mouse anti-γ-H2AX or mouse anti-p21 for 30 min (see Supplementary Table 23) , followed by a further 15 min incubation with Alexa Fluor 488 anti-mouse IgG (1:100, no. A-11029, Invitrogen) or anti-mouse E-Phycoerythrin (1:100, Invitrogen). EdU was detected with a Click-iT EdU Cell Proliferation Assay kit (Invitrogen-C10420).
For MCM2 staining, cells were washed once in wash buffer (1% (w/v) BSA in PBS), while unbound MCM2-7 was extracted in freshly prepared CSK buffer (10 mM HEPES, 100 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA, 300 mM sucrose, 1% (w/v) BSA, 0.2% (w/v) Triton-X100, 1 mM dithiothreitol, 1 mM phenylmethyl sulfonyl fluoride, 10 ng ml −1 pepstatin, 10 ng ml −1 leupeptin and 10 ng ml −1 aprotinin) on ice for 10 min. Extracted cells were then fixed in 2% (v/v) paraformaldehyde in PBS for 10 min at 37 • C, washed twice in wash buffer and stored in wash buffer at 4 • C until staining. CSK-extracted fixed cells were permeabilized in ice-cold 70% (v/v) ethanol for 10 min at room temperature, washed in wash buffer and incubated for 1 h at room temperature with mouse monoclonal anti-human MCM2 (BM28 no. 610700, BD Biosciences) diluted 1:500 in wash buffer. Cells were then washed once in wash buffer and incubated for 30 min at room temperature in the dark with Alexa Fluor 488 goat anti-mouse secondary antibody (no. A-11029, Invitrogen) diluted 1:500 in wash buffer, before being washed twice in wash buffer and resuspended in 50 µg ml −1 7-AAD (7-aminoactinomycin D, Life Technologies) diluted in wash buffer. Samples were analysed using FACS Canto (Becton Dickinson) and the BD FACS DIVA software (BD Biosciences). Data analysis was performed using Flowjo (version 7.6.5, Tree Star Inc.). To quantify G1 MCM levels, the Flowjo software was used to gate on cells with a G1 DNA content and then the mean, median, and 95th and 99th percentiles of the Alexa Fluor 488 levels in the G1 cells were calculated for each replicate; the data are presented with the background mean, median, 95th percentile or 99th percentile subtracted to correct for the increase in auto-fluorescence.
Senescence staining. Control (OFF) and induced (ON) Saos2 p21 Tet-ON or MDAH041 p21
Tet-ON cells were fixed in 1% paraformaldehyde and then processed for SA-β-gal or Sudan Black B staining and counterstained with nuclear fast red, as described elsewhere 66 . Only cytoplasmic staining was scored as positive signal.
MTT assay. Cytotoxicity was estimated by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay 12 . Data from three independent measurements were averaged and the corresponding s.d. is also reported.
Soft agar and invasion assays. Soft agar and invasion assays were performed as described elsewhere 12 . Experiments were performed in three independent replicates.
In vitro tumour sphere formation assays. Saos2 Tet-On p21 (10 4 ) cells were suspended in sphere formation medium (serum-free DMEM/F12 medium (Invitrogen) supplemented with 20 ng ml −1 epidermal growth factor (EGF, Sigma), 20 ng ml −1 basic fibroblast growth factor (bFGF, Sigma) and 1× B27 supplement (Invitrogen)) in ultralow-attachment 6-well plates (Corning). Cells were cultured under 5% CO 2 at 37 • C for 15 days. The number of generated spheres were counted and sized under an inverted microscope (Axiovert S100; Carl Zeiss) equipped with CP-Achromat objectives. Subsequently, medium with spheres was aspirated, treated with trypsin to dissociate cells from spheres and centrifuged (Fig. 8k) . Cell pellets were resuspended in fresh medium, counted and plated on soft agar, as previously described 12 . Data from three independent measurements from this combined procedure were averaged and the corresponding s.d. is reported.
Molecular cytogenetics. Molecular cytogenetics analyses were conducted as previously reported 12 . Cytogenetic analyses were performed using a 63× magnification lens on a fluorescent Axio-Imager Z1, Zeiss microscope, equipped with a MetaSystems CCD camera and the MetaSystems Isis software.
High-throughput analyses. Proteomics. Total protein was extracted from two biological replicates of non-induced and 12-h-, 48-h-and 96-h-induced Saos2-p21 Tet-ON cells (n = 2 experiments), where protein digestion and 8plex-iTRAQ labelling was performed as previously described 16 . The pooled whole sample was split in two equal parts lyophilized and stored at −20 • C. To the first half of the aforementioned iTRAQ-labelled sample high-pH reverse-phase peptide fractionation was performed as previously described 16 . The second half of the iTRAQ-labelled peptides was fractionated with hydrophilic interaction chromatography as previously described 68 . The individual high-pH reverse-phase and HILIC peptide fractions were analysed by LC-MS/MS followed by database searching as previously described 69 .
High-throughput whole-genome analyses. aCGH analysis. Genomic DNA from 30 days induced and non-induced Saos2-and Li-Fraumeni-p21 Tet-ON cells was extracted using the BioRobot M48 System (Qiagen) and the MagAttract DNA Blood Midi M48 Kit (Qiagen). Quality and quantity of the DNA samples was determined on a NanoDrop ND-1000 UV-VIS spectrophotometer. Agilent Human Genome CGH 4 × 180 K (to analyse Saos2-p21 escaped and non-induced, each comprising two biological replicates) and 1 × 1 MK (to analyse Saos2-p21 escaped and non-induced, each comprising two biological replicates; and Li-Fraumeni-p21 escaped and non-induced, each comprising three biological replicates, (n = 3)) microarrays were used. Labelling and hybridization was carried out according to the manufacturer's guidelines. Data were processed using Feature Extraction 10.7.3.1 and analysed using Cytogenomics 2.7.22.0 software (Agilent) with the following settings: Algorithm: ADM-1, Threshold: 6.7, with a minimum of four probes for a region to be included. Centralization and fuzzy zero corrections were applied to remove putative variant intervals with small average log 2 ratios as compared to the noise level that was determined by the system.
Whole-genome sequencing (WGS). Genomic DNA from two biological replicates obtained at 30 days' induction and non-induction of Saos2-and Li-Fraumeni-p21 Tet-ON cells, respectively, was used for WGS. The library preparation and the WGS were carried out in the Greek Genome Center (GGC) of Biomedical Research Foundation of Academy of Athens (BRFAA) and in EMBL Genecore facility.
WGS was performed achieving 20-30× coverage of the human genome with paired-end sequencing (2 × 150 and 2 × 100 bp). Quality control was performed with fastqc software 70 and alignment to the human genome (GRCh37/hg19 version) was performed with the bowtie2 algorithm 71 . Samtools 72 was used to convert sam files to bam and for sorting bam files. Breakdancer software 73 (breakdancer-1.1-2011_02_21 version) was utilized to identify SV (intra-and inter-chromosomal translocations, deletions, insertions and inversions).
Use of breakdancer with default parameters led to identification of new inter-chromosomal translocations in 'ON' versus 'OFF' cells in both cell types ( Supplementary Fig. 7 ). To identify microhomology regions in the interchromosomal translocations observed in both systems we used the coordinates from the breakdancer output and extended 30 bp on both sides of the breakpoint junction. Clustal W was used for aligning the regions around the breakpoint junctions. Microhomology regions identified on the breakpoint spanned from 2-38 bp.
RNA-seq analysis. RNA was collected from non-induced, 10 days (10 d) and 'escaped' Li-Fraumeni p21 Tet-ON cells (six biological replicates for escaped (n = 6) and four biological replicates for non-induced (n = 4)). RNA-seq library preparation and analysis procedure was performed as described before 8 . Expression microarray analysis. Total RNA was isolated from three biological replicates of non-induced and 12-h-, 48-h-and 96-h-induced Saos2-p21 Tet-ON cells (n = 3), using the RNeasy Total RNA kit (Qiagen) following the manufacturer's instructions. Microarray analysis was performed by the microarray unit of CBM Core Facility Italy (http://www.cbm.fvg.it) using Illumina's Whole-Genome Expression Beadchip. Integrity of total RNA was evaluated using capillary electrophoresis (Bioanalyzer 2100, Agilent) and quantified using a Nanodrop 1000. Aliquots of RNA (250 ng) samples were amplified according to specifications of the Illumina TotalPrep RNA Amplification Kit (Ambion) to produce a pool of biotinlabelled RNA corresponding to the polyadenylated (mRNA) fraction. The cRNA samples were applied to whole-genome HumanHT-12 v4.0 arrays (Illumina) and hybridized according to the manufacturer's specification. The signal intensities from the hybridization images were extracted and background subtracted using Illumina BeadStudio (v3.3.7). Data were checked for the Illumina internal quality control.
Total RNA was extracted from the non-induced and 'escaped' Saos2-p21 Tet-ON cells using Trizol (Life Technologies) and chloroform/isoamyl alcohol (49:1) (four biological replicates for escaped (n = 4) and three biological replicates for non-induced (n = 3)). Targets were prepared using the GeneChip Whole Transcriptome (WT) Plus reagent kit and hybridized to Affymetrix GeneChip Human Transcriptome array 2.0 (HTA 2.0). The obtained Saos2-p21 transcriptome profile was compared with the Li-Fraumeni p21 transcriptome profile obtained by RNA-seq.
Bioinformatic analysis. Transcriptome and proteome analyses from non-induced, 12-h-, 48-h-and 96-h-induced Saos2-p21 Tet-ON cells. Protein and gene ratios (time point/time 0) were log 2 transformed and centred. Statistically significant differentially expressed genes and proteins (P < 0.05) were determined by normal distributions of the log 2 ratios and ANOVA plus Kruskal-Wallis (Kruskal-Wallis only for the transcriptome data set where n = 3) since there was more than one DOI: 10.1038/ncb3378 time point. For the proteomic data set that consisted of two biological replicates, ANOVA was used on the basis of the conclusion of previous reports 74 that there are no principal objections to using t-tests and ANOVA with sample replicates as small as 2. All calculations were performed with R. The 'Gene-Set Enrichment Analysis' on the Gene Ontology biological process set was performed as previously described 16 . Pathway visualization for all data sets was performed with Ariadne Genomics Pathway Studio v9.0.
Transcriptome analysis from non-induced and 'escaped' Saos2-p21 Tet-ON cells. Affymetrix .CEL files were normalized with the Robust Multi-array Average (RMA) algorithm. Data were further analysed by principal component analysis and oneway ANOVA (P < 0.05). Differentially expressed transcripts were analysed using the Ingenuity Pathway Analysis software considering all direct and indirect relationships obtained only from experimentally verified information.
WGS and aCGH data comparison. To compare the WGS data with the aCGH data regarding DNA copy-number aberrations in 'escaped' (ON) cells versus control (OFF) cells (both in Saos2 and Li-Fraumeni systems), the WGS data were processed as follows: genomic regions presenting less than 10-times coverage were filtered out to ensure data high quality; the log 2 of the ratio of the normalized reads in the 'escaped' cells over the normalized number of reads in the control cells was calculated; for each chromosome the aforementioned log 2 ratios underwent DNA copy-number segmentation analysis using the circular binary segmentation algorithm through the Bioconductor package 'DNAcopy' 75 . Assessment of randomness in the overlap between the transcriptomics and aCGH data through Monte Carlo simulation. To access the probability of the observed overlap between the transcriptionally affected genes (DNA-microarray for Saos2 and RNA-Seq for Li-Fraumeni p21 Tet-ON systems) and the genes present in the significantly affected genomic regions (aCGH data) being due to chance, a Monte Carlo simulation approach was utilized. Specifically, the genes present on the corresponding transcriptomics analysis platform (DNA-microarray for Saos2 and RNA-Seq for Li-Fraumeni) were randomly sampled 10 4 times with a sample size equal to the number of significantly regulated genes. For each random sampling the overlap with the genes present in regions exhibiting genomic aberrations according to aCGH was calculated. The distribution of the number of overlaps was found to be normal according to the Kolmogorov-Smirnov test for normality; hence, the P value of the observed overlap in our data was calculated. That P value represents the probability of the observed overlap to belong to the distribution of the randomly generated overlaps, therefore being due to chance alone. All statistical analysis was carried out with R. Pathway Analysis. Proteomics and transcriptomics data were analysed with Ariadne Pathway Studio v9.0 as previously described 16 .
Statistics and reproducibility. Parametric (two-sided t-test and one-way ANOVA) and non-parametric tests (Mann-Whitney and Kolmogorov-Smirnov test for normality), were used for hypothesis testing with P values < 0.05 considered as significant. Data availability. Microarray and aCGH data that support the findings of the study have been deposited in the Gene Expression Omnibus (GEO) under the accession codes GSE62166 (microarray) and GSE81754 (aCGH). RNAseq and WGS data have been deposited in the Short Read Archive (SRA) under the accession codes SRP074688 (RNAseq) and SRP074843, SRP045212, SRP075021 and SRP075022 (WGS).
The proteomics data set was deposited at the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD004140.
Source data for . Source data can be found in Supplementary Table 25 . Potential mechanism for p73 down-regulation fvii. Table 5 ). The majority of aberrations were concentrated in chromosomes 3, 10 and X (Supplemental Table 5 In addition, cells #2, #4 and #9, have lost a marker translocation der(9) t(5;9) that was replaced by a deletion 9p and acquired clonally an extra translocated der(22)t (20;22) . A unique subclonal finding in Cells #3 and #10, of the "escaped" (ON) cells is the persistence of der(9)t(5;9). Cells #5 and #7 represent two different endoreduplicated ON subclones, characterized by unique structural abnormalities of chromosomes 7, 15 and 6 respectively. The karyotypic constitution of cell #8, resembles that of the control population and justifies the presence of an additional subclone that does not exceed the 10% of the "escaped" (ON) cells. (CIN:chromosomal instability)
Suppl. Figure 6
Concordance between aCGH and NGS analyses in Saos2 p21 WAF1 Tet-ON cells a. Supplementary Figure 9 Unprocessed blots/gels employed in the current manuscript.
